CombiMatrix Corp. (CBMX) Contracts with Galaxy Health Network

Molecular diagnostics company CombiMatrix Corporation announced it has entered into a contractual agreement with Texas-based Galaxy Health Network for coverage of CombiMatrix’s diagnostic laboratory services.

Based in Arlington, Texas, Galaxy Health Network has a provider base that includes more than 400,000 directly contracted physicians, 2,700 hospitals, and 47,000 ancillary providers. The network’s member base currently encompasses more than 3.5 million covered members who now have access to CombiMatrix’s suite of molecular diagnostic solutions and comprehensive clinical support, with specialization in prenatal, miscarriage, and pediatric healthcare.

Partnering with Galaxy gives CombiMatrix an additional opportunity to broaden its payor geographic reach, further expanding the company’s presence throughout the U.S. and providing much broader access to its full portfolio of testing services, including the CombiSNP chromosomal microarray test.

The partnership also enables CombiMatrix and Galaxy to work together in educating physicians in the Galaxy network about the benefits of chromosomal microarray testing. CombiMatrix believes its services are vital for important health networks like Galaxy.

For more information, visit the CombiMatrix website at www.combimatrix.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html